Health Network Communications, London
2012-02-28
8.30am Registration and coffee
8.50am Opening remarks from the Chair
Guy Clark
Guy joined Goldshield in August 2010 as its Business Development Director, with responsibility for the strategic development of this evolving specialty pharma company, under new ownership and management since the beginning of 2010. Guy is... more..
› Guy Clark, Business Development Director, Goldshield Group Limited
STRATEGIC OVERVIEW
9am Generic medicines health check – view from the investment community
Dominic Hollamby
Dominic is a Vice Chairman of Rothschild in London and also holds the position of Global Head of Healthcare. He has been at Rothschild since 1998. As an experienced M&A practitioner focused on the healthcare industry, he has a long track record of ... more..
• Current trends in M&A pharma and generics • Big pharma and generics convergence • Impact of health economics and budgetary pressures
› Dominic Hollamby, Vice Chairman, Rothschild
9.30am The sustainability of healthcare in Europe
• Pro-generic environment • Healthy competition • Uniform quality standards across the globe Speaker to be confirmed
10am Speed Networking and Morning Refreshments
10.30am Keynote Building a business - a leaders view
• Hospira's generics and biogenerics experience in Europe • Hospira's R&D pipeline and strategy • Expanding capabilities through partnering, acquisitions and mergers • Summary and thoughts for the future
› Ron Squarer, Chief Commercial Officer, Hospira
11.30am Keynote: Building global scale and market share in today’s generics market
Abhijit Mukherjee
Abhijit Mukherjee is the President - Global Generics business of Dr. Reddy’s and is responsible for Manufacturing, Sales & Marketing Operations of the largest Business unit of the company (Revenues from Global Generics business in FY11 stood at US$...
more..
• Defining the scope and diverse mix of global generics market • The critical success factors to achieve scale and market share in each market • The key challenges the generic industry is likely to face in order to achieve these objectives
› Abhijit Mukherjee, President Global Generics, Dr Reddy's
12pm Keynote: Affordable medicine strategy – building value and successful generics portfolio in an increasing competitive market
Anish Mehta
ANISH MEHTA has been with Watson Pharmaceuticals for 2 years and serves as the Vice President of European Generics. In this role, he is responsible for managing and growing Watson’s European Generics business. Prior to joining...
more..
• The changing landscapes of the generics industry • Challenges and opportunities in an increasingly competitive market • Building a sustainable business model for the future
› Anish Mehta, Vice President European Generics, Watson
IP DEVELOPMENTS
12.30pm International IP
Dr Aman Trehan
Dr. Aman Trehan is head of Global Intellectual Property at Pharmaceutical Technology Centre of Zydus Cadila Healthcare Ltd. He obtained his doctorate in Pharmaceutical Sciences from Panjab University, India. He has worked in various multinational...
more..
• Patent use strategies: originator v generics • Overview of comparison of patent system between US and Europe • Overview of comparison of litigation system between US and Europe
› Dr Aman Trehan, General Manager and Head Glonal Intellectual Property, Zydus Cadila
1pm Lunch
POLICY REVIEW
2pm Keynote: Congressional update and Q&A session on US legislation on generics
Henry Waxman
Representative Henry A. Waxman represents California's 30th Congressional District, which includes the cities of Santa Monica, Beverly Hills, Agoura Hills, Calabasas, Hidden Hills, Malibu, Westlake Village and West Hollywood, as well as such areas...
more..
› Henry Waxman, Member of Congress, Congress- United State of America
2.30pm Update of US Health Care Reform and impact of recent US legislation on generics
Juliana Reed
Juliana Reed is the Vice President of Government Affairs for Hospira, Inc where she has overall responsibility for the Government Relations function which includes the oversight of global government relations and public policy initiatives for the... more..
• Update on the implementation of healthcare reform • Prospects for health care legislation this year
› Juliana Reed, Vice President, Government Affairs, Hospira
3pm European industrial policy for generic medicines
Paul Csiszar
After graduating from ELTE School of Law of Budapest, Paul Csiszár studied international comparative law and earned a second JD at Loyola Law School in the United States. Following his admission to the bar in 1986 in California he practiced as a...
more..
• Monitoring and enforcement exercise • Patent settlements • European competition law
› Paul Csiszar, Competition Directorate General Director, Basic Industries, Manufacturing and Agriculture, European Commission
3.30pm Afternoon refreshments
4pm Purchasers perspective on cost containment and generic prescribing in Germany
Dr Corelius Erbe
Dr. Cornelius Erbe is currently holding a position as senior vice president and member of the extended Board of Deutsche Angestellten-Krankenkasse (DAK); Hamburg/Germany. DAK is the third largest German statutory health insurance organization with...
more..
• A German payer's perspective on cost containment and generic prescribing • Actual situation in Germany - legal framework and market conditions • AMNOG: The impact on pricing procedures • Strategic positioning of DAK
› Dr Corelius Erbe, Member of the Extended Board - Head of Product Management, DAK
5pm Review of market dynamics in Germany and the opportunities and treats from tenders
Michael Ewers
Since November 2008 Michael Ewers is Managing Director/CEO of betapharm Arzneimittel GmbH in Augsburg, which is a subsidiary of the international pharmaceutical company Dr. Reddy's Laboratories, headquartered in Hyderabad, India. Ewers started his...
more..
• Market dynamics in generics in Germany • Implementation of tender contracts • Consequences for the German Generic industry
› Michael Ewers, CEO & Managin Director, betapharm Arzneimittel GmbH
5.30pm Closing remarks from the Chair
7.30pm The World Generic Medicine Congress Gala Dinner is an opportunity to relax and network over a few drinks and enjoy great food with your fellow attendees.
Hear a truly inspirational speech from Pete Goss MBE. It’s a great story; during the yacht race Pete ended up rescuing a Frenchman deep in the southern ocean on Christmas day and a month later had to operate on himself in the Pacific Ocean. It’s interesting, funny, moving and very motivational. Pete loves what he does and looks forward to sharing one of his favourite adventures with you. (Please note this is an additional cost)
8.30am Registration and coffee
8.50am Opening remarks
Dr Brian Tempest
Dr Brian Tempest advises Companies, Banks, Investment Funds, Private Equity & High Net Worth Individuals on their Strategy in Asia based on his wide experience in China, Japan, South East Asia and India where he has lived for the last decade. Brian...
more..
› Dr Brian Tempest, Chairman, Hale & Tempest
BIOSIMILARS
9am Market and sales review of biosimilars in Europe
Michael Kotsanis
Michael Kotsanis has over 20 years of experience in the pharmaceutical industry and has significant senior leadership experience across the global pharmaceutical markets. He is the Chief Commercial Officer for Synthon, a position he has held since... more..
• Biosimilars are the fastest growing market segment in the long term for generics • Performance of biosimilars in Europe to date • Prospects for biosimilars in Europe in the future • Barriers and opportunities for market adoption in the future
› Michael Kotsanis, Chief Commerical Officer, Synthon Bv
9.30am Operational realities of building a biosimilar and biobetter development strategy
• Strategies to enter the lucrative field • Polpharma’s biosimilar development approaches
› Dr Klaus Martin, Head Biologics, Polpharma
10am Commercial challenges with launching biosimilars
• The competitive landscape • Market factors influencing uptake of biosimilars • Implications for biosimilars
› Peter Stenico, Head Commercial Operations, Western Europe, Sandoz
10.30am Morning Refreshments
BIG PHARMA AND GENERICS
11am Pfizer's commitment to provide quality sterile injectables essential to the health and well-being of patients
• Characteristics of the hospital business in Europe and Emerging Markets • Pfizer’s strategy in the hospital market • The importance of quality and supply reliability in the Sterile Injectables business
› Gregor Siebert, Vice President Hospital Europe, Established Products Business, Pfizer
PRODUCT DIFFERENTIATION AND FOCUS
11.30am Building scale, market share and value through differentiation
Rahul Garella
Rahul Garella is an experienced pharmaceutical executive with more than fifteen years of experience in the pharmaceutical business across the segments of Active pharmaceutical ingredients (APIs) and generic formulations. He currently heads up the...
more..
• How the European markets have changed in the last few years and the implications this has for generic players • Why building scale is not just about products • Commercial innovation as the bedfellow of product innovation • The Glenmark model to building value
› Rahul Garella, Senior Vice President - EU Business, Glenmark Generics
12pm Review of launching, marketing and selling generic respiratory products
George Kapitsakis
Work Experience Jun 2011 to Present Group Product Manager in Respiratory Department in ELPEN Pharmaceutical Co. Inc. Jul 2009 - Jun 2011 Senior Product Manager in Respiratory Department in ELPEN Pharmaceutical Co. Inc. Jan 2007 – Jul 2009 Product...
more..
• Pre-launching activities • Marketing strategy vs originator • Major messages • Launching activities
› George Kapitsakis, Group product Manager, Respiratory Products, Elpen Pharmaceutical Co.
12.30pm Lunch
INTERNATIONAL MARKET FOCUS
1.30pm Cost containment, generics prescribing and challenges
› Dr Ullrich Hanstein, General Manager, HELP S.A.
2pm The API manufacturing in CEE and the market dynamics
• Overcapacity and outsourcing opportunities constraints • Growing competition posed by low-cost manufacturers in Asia • Regulatory changes that have and are expected to influence the industry • New Technologies as a global trend • IP and legal landscape • Partnerships as a critical global trend
2.30pm Review of market dynamics in Japan
Yoshifumi Togo
Mr. Togo is the Deputy General Manager, Management Planning Development Department of Towa Pharmaceutical Co., Ltd. He started his business career in Yoshitomi Pharmaceutical (Existing Mitsubishi Tanabe Pharma Corporation) as a medicinal chemist...
more..
• Government promotion of generic medicines and trends of generic penetration • Challenges & opportunities for generic players • Future of Japanese generic market
› Yoshifumi Togo, Deputy General Manager, Management Planning Development Department, Towa Pharmaceutical Co., Ltd.
3pm Afternoon Refreshments
3.30pm Opportunities and challenges for generic industry: overview of changing paradigm especially in emerging markets such as China
Jack Aurora
Dr. Jack Aurora is Ph.D. in pharmaceutical sciences with over 19 years of Quality and Compliance driven research and management experience to his credit. Dr. Aurora’s research experience is in all the dosage forms including but not limiting to...
more..
• What do the emerging markets offer and how to make the most of it? • Is it fare to believe that a single strategy is sufficient for fragmented nature of the emerging markets? • At the end, what is to be focused to survive and sustain the business, do we see a crystal ball somewhere?
› Jack Aurora, Chief Scientific Officer & R&D Director Generic Drugs, Hisun Pharmaceuticals
4pm Review of market dynamics in Brazil
Vinzenz Plorer
Vinzenz Plorer is Vice President Operations at EMS Pharma in charge of unbranded generics business, branded generics business, hospital business and international business. EMS is the leading pharmaceutical company in Brazil with around 10% market...
more..
• Why the Brazilian market grows 2 times as whole quicker than Latin America and 4 times quicker than Europe • Registration and market strategies for emerging market • How to keep the leader ship in generics as local company - competing with Multinationals
› Vinzenz Plorer, Vice President , Operations, EMS Brazil
4.30pm Closing Remarks from the Chair
|